Lupin Licenses Biosimilar Ranibizumab for Latin American Markets

Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...

Syngene Targets Brain Biomarker to Boost Anxiety Drug Research

In the developing side of drug development for mood and anxiety disorders, Syngene has stressed the critical need to precisely measure

Dr Reddy's API Unit in Telangana Gets 2 USFDA Observations

After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...

XTANDI Extends Survival in Metastatic Hormone-Sensitive Prostate Cancer

Astellas Pharma and Pfizer have reported new updated long-term results from the open-label extension portion of the Phase 3 ARCHES study that utilized a five-year follow-up to demonstrate continued overall survival (OS) benefits...

Lincoln Pharmaceuticals reports Net Profit of Rs. 82.44 crore

Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported a standalone net profit of Rs. 82.44 crore for the FY25 ended March 2025 as against net profit of Rs. 93.37 crore FY24.

Delhi Govt Issues Advisory to Hospitals Amid Rise in COVID Cases

Due to the recent increase in COVID-19 cases, the Delhi government has issued advisory commending hospitals to raise preparedness,

Alembic Gets USFDA Approval for generic high blood pressure treatment drug

Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets USP...

Indoco Gets US FDA Nod for Allopurinol 200 mg Tablets

Indoco Remedies Ltd., a research focused pharmaceutical company, has received final approval from the US Food and drug Administration

Zydus to Launch Single Pen for Adjustable Semaglutide Doses

Zydus Lifesciences is developing a new semaglutide formulation for diabetes and obesity, two rapidly growing chronic conditions that are becoming increasingly debilitating. Rather than requiring patients to...

Gujarat Set to Approve Surat Drug Lab, Says FDCA Chief

Dr. Hemant G. Koshia, Commissioner of the Food and Drug Control Administration (FDCA) stated that the Gujarat government is in the final stage of approving a high-tech drug testing laboratory in Surat.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.